Conference panels, speaker features, institutional awards, event sponsorships, and press coverage positioning MoatRx at the forefront of pharma commercial consulting.
MoatRx Founder in conversation at the Global Capability Centres Summit and Awards 2026, discussing how pharma commercial GCCs can close the execution gap and scale from cost centres to innovation engines.
MoatRx on the main stage, panelist on "Pharma GCCs as Enterprise Innovation Engines", alongside leaders from Opella, AbbVie, and Kaneka. 11 March 2026, The Westin Hyderabad Mindspace.

MoatRx joined pharma and life sciences leaders on the panel "Building Intelligent, Scalable and Cost-Optimised Global Platforms", examining how commercial GCCs evolve from delivery units to strategic assets.

MoatRx listed as a Supporting Partner on the official summit partner wall alongside LEAP, ERO Power, Marksmen Daily, In Focus, and Business Standard. MoatRx Founder formally designated as Eminent Speaker by Team Marksmen.
MoatRx as Associate Sponsor and featured speaker at Samanvay 2026. Panel: "Inside the Founder Mindset." Sheraton Hyderabad, 12 April 2026.




Inside the Founder Mindset: Applying Entrepreneurial and Intrapreneurial Mindsets to Accelerate Careers in Life Sciences
Featured speaker on the founders panel. Associate Sponsor. Memento presented by conference organisers at close of session.
Samanvay 2026, powered by AdametNeXt. 12 April 2026. Sheraton, Hyderabad. Pharma leaders across India.
MoatRx at one of Asia's most influential life sciences and biotechnology conferences. 17–18 February 2026, Hall 4, HITEX Exhibition Centre, Hyderabad.
MoatRx at BioAsia 2026, Asia's premier life sciences conference, engaging with pharma commercial leaders on GCC maturity models, commercial operations excellence, and AI readiness for life sciences commercial functions.
Topics covered: GCC Maturity Models · Commercial Ops Excellence · AI Readiness for Pharma Commercial Teams
MoatRx Founder recognised at the SIES Alumni Meet 2026 for outstanding entrepreneurial achievement in the pharmaceutical industry.
The SIES Centre for Alumni Relations presented the Distinguished Alumni Award to the Founder of MoatRx, recognising outstanding achievement in founding and scaling a specialised pharma commercial consulting firm.
The award recognises MoatRx's contribution to advancing execution excellence and commercial operations discipline in the life sciences industry across global markets.
Business press, thought leadership, and media features on MoatRx's consulting model and approach to pharma commercial execution.

Consulting-grade pharma intelligence briefs, competitive analysis, patient sizing models and market access insights delivered in hours instead of weeks.
Read the article →
Coverage of the AXLRx launch in Marksmen Daily's Brand Speak section, on the platform's approach to consulting-grade pharma commercial research.
Read the article →
Eight consulting-grade research solutions for pharma companies, from a firm specialising in commercial operations across the GCC and global markets.
Read the article →
How MoatRx built a consulting model around execution excellence, closing the gap between pharma strategy and measurable commercial outcomes. 5,134 views.
Read the article →
MoatRx's framework for treating operational excellence as competitive infrastructure, not an outcome, published in Marksmen Daily's business section.
Read the article →
BusinessPress profiles MoatRx's consulting approach, specialising in the execution layer of pharma commercial operations across GCC and global markets.
Read the article →
MoatRx's execution framework syndicated to Dailyhunt's 300M+ user platform across India, reaching pharma professionals and business leaders nationwide.
Read the article →
CXO Digital Pulse covers the summit where MoatRx served as Supporting Partner and featured speaker, examining India's GCC landscape for pharma commercial operations.
Read the article →"MoatRx was built on a single conviction: execution is the competitive advantage that strategies alone cannot deliver."MoatRx Consulting · as featured in Startup Times and Marksmen Daily, 2026